A heparan sulfate-based matrix therapy reduces brain damage and enhances functional recovery following strokeYacine Khelif, Myriam Bernaudin, Jérôme Toutain et al.|Theranostics|2018Cited by 22
Genetic variability in proteoglycan biosynthetic genes reveals new facets of heparan sulfate diversity.Mohand Ouidir Ouidja, Dulce Papy-García, Denis Biard et al.|PubMed|2024Cited by 3
Variability in proteoglycan biosynthetic genes reveals new facets of heparan sulfates diversity. A systematic review and analysisMohand Ouidir Ouidja, Dulce Papy-García, Denis Biard et al.|medRxiv|2022Cited by 1
A combination of stem cells and an extracellular matrix agent as a new therapeutic strategy for ischemic strokeYacine Khelif, Myriam Bernaudin, Rozenn Le Gal et al.|HAL (Le Centre pour la Communication Scientifique Directe)|2019Cited by 0
Heparan sulfate: <i>In vitro</i> and <i>in vivo</i> proof of efficacy of this new therapeutic strategy for halting Alzheimer disease‐related tauopathy developmentAuriane Maïza, Dulce Papy-García, Gael Le Douaron et al.|Alzheimer s & Dementia|2021Cited by 0